Total number of publications: 160
2024
-
Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy - obstacles and perspectives
TRANSCRIPTION-AUSTIN, year: 2024, DOI
-
Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2
Journal of Medicinal Chemistry, year: 2024, volume: 67, edition: 15, DOI
-
eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations
Proceedings of the National Academy of Sciences of the United States of America, year: 2024, volume: 121, edition: 44, DOI
-
Lipidomic analysis of tetraspanin-deficient extracellular vesicles
Year: 2024, type: Conference abstract
-
Lipidomic profiling of extracellular vesicles from tetraspanin-deficient cell lines
Year: 2024, type: Conference abstract
-
Orthotopic model for the analysis of melanoma circulating tumor cells
Scientific Reports, year: 2024, volume: 14, edition: 1, DOI
-
Proteomic analysis of tetraspanin-deficient extracellular vesicles
Year: 2024, type: Conference abstract
-
Single-cell profiling of surface glycosphingolipids opens a new dimension for deconvolution of breast cancer intratumoral heterogeneity and phenotypic plasticity
JOURNAL OF LIPID RESEARCH, year: 2024, volume: 65, edition: 9, DOI
-
Thieno[3,2-b]pyridine: Attractive scaffold for highly selective inhibitors of underexplored protein kinases with variable binding mode
Angewandte Chemie International Edition, year: 2024, DOI
2023
-
Circulating tumor cell-derived preclinical models: current status and future perspectives
Cell Death and Disease, year: 2023, volume: 14, edition: 8, DOI